TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2420105

Group type: EXPERIMENTAL
Intervention: Dextran 70
Number of subjects: 65

Group type: COMPARATOR
Intervention: Dextran 70 + Dihydroergotamine
Number of subjects: 65
Study: 30914044

Group type: EXPERIMENTAL
Intervention: Delayed antibiotic prescription (DAP)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Delayed antibiotic prescription (DAP) for respiratory tract infections (RTIs)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Participation in the DAP RCT
Number of subjects: 215

Group type: COMPARATOR
Intervention: Previous use of DAP
Number of subjects: 215

Group type: COMPARATOR
Intervention: Profession type (physician vs nurse)
Number of subjects: 215
Study: 30413542

Group type: COMPARATOR
Intervention: Mailed letter
Number of subjects: 5270

Group type: EXPERIMENTAL
Intervention: Phone call
Number of subjects: 5270
Study: 26317322

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus paclitaxel
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo plus paclitaxel
Number of subjects: 223
Study: 25266473

Group type: EXPERIMENTAL
Intervention: Humor skill training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (doing handwork)
Number of subjects: 30
Study: 22782352

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg daily for 14 days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 20107799

Group type: EXPERIMENTAL
Intervention: Suramin plus docetaxel 75 mg/m²
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Suramin plus docetaxel 56 mg/m²
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Suramin plus gemcitabine 1,250 mg/m²
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Suramin (general)
Number of subjects: 18
Study: 18485031

Group type: EXPERIMENTAL
Intervention: Suspension technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: No suspension technique
Number of subjects: 60
Study: 16269000

Group type: EXPERIMENTAL
Intervention: Sonic Complete (SC) toothbrush
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Sonicare Elite (SE) toothbrush
Number of subjects: 34

Group type: COMPARATOR
Intervention: Both brushes
Number of subjects: 34
Study: 12122554

Group type: EXPERIMENTAL
Intervention: SSM+ (semisolid meal with 2.5 g GG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: SM (solid meal)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: SSM+
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: SM
Number of subjects: 15

Group type: COMPARATOR
Intervention: SSM
Number of subjects: 15
Study: 10774648

Group type: EXPERIMENTAL
Intervention: Permethrin-impregnated bed nets
Number of subjects: 0
Study: 7494721

Group type: EXPERIMENTAL
Intervention: Medication group program aimed at diminishing affective components of negative attitudes towards neuroleptics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 2089252

Group type: EXPERIMENTAL
Intervention: Low-dose calcitriol (0.25 microgram b.i.d.) and 1 g of supplemental calcium therapy
Number of subjects: 4

Group type: COMPARATOR
Intervention: Ergocalciferol (50,000 units twice a week) and 1 g of supplemental calcium
Number of subjects: 4
Study: 360761

Group type: EXPERIMENTAL
Intervention: Deanol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30470666

Group type: EXPERIMENTAL
Intervention: Exercise intervention (EG): moderate aerobic exercise performed three days per week (50‐55 minutes per session) for 8‐10 weeks to 38‐39 weeks gestation.
Number of subjects: 456

Group type: COMPARATOR
Intervention: Standard care control (CG): no specific intervention mentioned.
Number of subjects: 456
Study: 29097659

Group type: EXPERIMENTAL
Intervention: Model A educational intervention (three-stage)
Number of subjects: 1690

Group type: EXPERIMENTAL
Intervention: Model B educational intervention (two-stage)
Number of subjects: 1690

Group type: EXPERIMENTAL
Intervention: Model C educational intervention (one-stage)
Number of subjects: 1690
Study: 25979441

Group type: EXPERIMENTAL
Intervention: Neonatal vitamin A supplementation
Number of subjects: 31999

Group type: EXPERIMENTAL
Intervention: Neonatal period
Number of subjects: 31999

Group type: EXPERIMENTAL
Intervention: Age 6-12 months
Number of subjects: 31999

Group type: EXPERIMENTAL
Intervention: Demographic and socioeconomic factors
Number of subjects: 31999

Group type: EXPERIMENTAL
Intervention: Environmental factors
Number of subjects: 31999
Study: 23001254

Group type: EXPERIMENTAL
Intervention: Continued ecstasy and/or amphetamine use (n=17)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Stopped ecstasy and/or amphetamine use (n=12)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 21586821

Group type: EXPERIMENTAL
Intervention: ctDCS (2 mA for 20 min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham tDCS (2 mA for 1 min)
Number of subjects: 10
Study: 19321575

Group type: EXPERIMENTAL
Intervention: 5 g/d seaweed (Alaria)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Soy supplementation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Seaweed plus soy (SeaSoy)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Soy for equol excretors
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: SeaSoy for equol producers
Number of subjects: 15
Study: 16481636

Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D supplementation (500 mg of elemental calcium as calcium carbonate with 200 IU of vitamin D3 twice daily for an average of 7.0 years)
Number of subjects: 36282

Group type: COMPARATOR
Intervention: Placebo (matching placebo for an average of 7.0 years)
Number of subjects: 36282
Study: 15503798

Group type: EXPERIMENTAL
Intervention: Specific vestibular exercises
Number of subjects: 58

Group type: COMPARATOR
Intervention: Non-specific exercises
Number of subjects: 58
Study: 11382835

Group type: EXPERIMENTAL
Intervention: Vascupump treatment (20 sessions of 45 minutes each)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combined treatment with Vascupump and Pentoxillin (3 fl/per diem for 20 days)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Pentoxillin alone (3 n per diem for 20 days)
Number of subjects: 36
Study: 9745422

Group type: EXPERIMENTAL
Intervention: Recombinant human IGF‐I (60 micrograms/kg), i.v., over 4 h
Number of subjects: 8
Study: 8058074

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg twice daily)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Digoxin (0.25 mg daily)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 143

Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 143
Study: 3405354

Group type: EXPERIMENTAL
Intervention: Early surgery (within 72 hours)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Late surgery (after 72 hours)
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Early surgery (stages IV and V)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Late surgery (stages IV and V)
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Early surgery
Number of subjects: 356

Group type: COMPARATOR
Intervention: Late surgery
Number of subjects: 356
Study: 31231136

Group type: EXPERIMENTAL
Intervention: Massively parallel shotgun sequencing (semiconductor-based)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Massively parallel shotgun sequencing (optical-based)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Both sequencing platforms
Number of subjects: 4000
Study: 28508579

Group type: EXPERIMENTAL
Intervention: Telephone Coaching (TC)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 37
Study: 26375689

Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonist liraglutide
Number of subjects: 0
Study: 24660607

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (10 sessions of puncturing acupuncture at various acupoints including Hegu (LI 4))
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-pressing right-hand Hegu (LI 4)
Number of subjects: 0
Study: 22180716

Group type: EXPERIMENTAL
Intervention: Laparoscopic hepatectomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open hepatectomy
Number of subjects: 60
Study: 18299944

Group type: EXPERIMENTAL
Intervention: Laparoscopic total fundoplication
Number of subjects: 167

Group type: COMPARATOR
Intervention: Laparoscopic anterior fundoplication
Number of subjects: 167
Study: 16442211

Group type: EXPERIMENTAL
Intervention: Tamsulosin OCAS 0.4 mg
Number of subjects: 58

Group type: COMPARATOR
Intervention: Alfuzosin XL 10 mg
Number of subjects: 58
Study: 14709244

Group type: EXPERIMENTAL
Intervention: Ribavirin (RBV) 400 mg bid plus interferon alpha‐2b (IFN‐alpha) 5 mU daily for the first 6 weeks, followed by 3 mU tiw until completing 6 months of therapy (induction arm)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Ribavirin (RBV) 400 mg bid plus interferon alpha‐2b (IFN‐alpha) 3 mU tiw (control arm)
Number of subjects: 106
Study: 11112016

Group type: EXPERIMENTAL
Intervention: High-dose ATG (9 mg/kg body weight, single intravenous injection)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Cyclosporine-based protocol (control group)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: High-dose ATG
Number of subjects: 38
Study: 9420308

Group type: EXPERIMENTAL
Intervention: Ritonavir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nevirapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zidovudine
Number of subjects: 0

Group type: COMPARATOR
Intervention: RT inhibitors (Nevirapine and Zidovudine)
Number of subjects: 0
Study: 8348707

Group type: EXPERIMENTAL
Intervention: 1 ampoule of FSH (cycle 1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 3 ampoules of FSH (cycle 3)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 6 ampoules of FSH (cycle 6)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (cycle P)
Number of subjects: 6
Study: 2872811

Group type: EXPERIMENTAL
Intervention: Terazosin (1 to 40 mg, single daily doses)
Number of subjects: 713

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 713
Study: 31125395

Group type: EXPERIMENTAL
Intervention: Cabotegravir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29387931

Group type: EXPERIMENTAL
Intervention: Single instillation of THP (30 mg/50 mL) immediately after TURBT (Group A)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Two-time instillation of THP immediately after and 1 day after TURBT (Group B)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 257
Study: 27643885

Group type: EXPERIMENTAL
Intervention: Vilazodone 20 mg/day
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Vilazodone 40 mg/day
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/day
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 25308780

Group type: EXPERIMENTAL
Intervention: i-gel size 1
Number of subjects: 40

Group type: COMPARATOR
Intervention: cLaryngeal Mask Airway size 1
Number of subjects: 40
Study: 23965882

Group type: EXPERIMENTAL
Intervention: MMF1 (mycophenolate mofetil after 2 weeks of conventional treatment)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: MMF2 (combination therapy with non-steroidal anti-inflammatory drugs, prednisone, and MMF)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (conventional treatment)
Number of subjects: 35
Study: 21970469

Group type: EXPERIMENTAL
Intervention: Wound-edge protection device
Number of subjects: 750

Group type: COMPARATOR
Intervention: No wound-edge protection device
Number of subjects: 750
Study: 18431048

Group type: EXPERIMENTAL
Intervention: Uterine fibroid embolization (UFE)
Number of subjects: 44
Study: 16868226

Group type: EXPERIMENTAL
Intervention: Goserelin (3.6 mg subcutaneously every 4 weeks for 12 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 22
Study: 12182257

Group type: EXPERIMENTAL
Intervention: Cefditoren 200 mg BID for 10 days
Number of subjects: 1685

Group type: EXPERIMENTAL
Intervention: Cefditoren 400 mg BID for 10 days
Number of subjects: 1685

Group type: COMPARATOR
Intervention: Cefuroxime 250 mg BID for 10 days
Number of subjects: 1685

Group type: COMPARATOR
Intervention: Cefadroxil 500 mg BID for 10 days
Number of subjects: 1685

Group type: COMPARATOR
Intervention: Cefditoren 200 mg vs Cefuroxime
Number of subjects: 1685

Group type: COMPARATOR
Intervention: Cefditoren 200 mg vs Cefadroxil
Number of subjects: 1685

Group type: COMPARATOR
Intervention: Cefditoren 400 mg vs Cefadroxil
Number of subjects: 1685

Group type: EXPERIMENTAL
Intervention: Cefditoren 400 mg
Number of subjects: 1685

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 1685
Study: 10482825

Group type: EXPERIMENTAL
Intervention: Fluconazole 100 mg daily for 5 months
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fluconazole (continued treatment in phase 2)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo for 5 months
Number of subjects: 11
Study: 8738765

Group type: EXPERIMENTAL
Intervention: Once-daily aminoglycoside dosing (ODA)
Number of subjects: 850
Study: 1951337

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 8
Study: 6783970

Group type: EXPERIMENTAL
Intervention: Mannitol (9 mosm/kg water)
Number of subjects: 13

Group type: COMPARATOR
Intervention: 5% glucose in water (control)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Ultrafiltration rate
Number of subjects: 13
Study: 31711969

Group type: EXPERIMENTAL
Intervention: PAINRelieveIt®
Number of subjects: 234

Group type: COMPARATOR
Intervention: Usual hospice care
Number of subjects: 234
Study: 30777094

Group type: EXPERIMENTAL
Intervention: Caffeine supplementation (GCAF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (GCON)
Number of subjects: 20
Study: 27280523

Group type: EXPERIMENTAL
Intervention: Integrated Psychological Therapy (IPT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 48
Study: 25057140

Group type: EXPERIMENTAL
Intervention: Live Educational Music Therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Recorded Educational Music Therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Recreational Music Therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Education without Music
Number of subjects: 96

Group type: COMPARATOR
Intervention: Recreational Music Therapy without Education
Number of subjects: 96
Study: 22324267

Group type: EXPERIMENTAL
Intervention: Clinical audits implemented by the Safe Motherhood Committee
Number of subjects: 3494

Group type: COMPARATOR
Intervention: Control group (3 other general hospitals without clinical audits)
Number of subjects: 3494
Study: 18964302

Group type: EXPERIMENTAL
Intervention: Rituximab and methimazole for 21 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methimazole alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rituximab therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 0
Study: 17219174

Group type: EXPERIMENTAL
Intervention: Intensified training (IT) for 6 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal training (NT) for 6 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intensified training (IT) followed by a 7-day taper
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal training (NT) followed by a 7-day taper
Number of subjects: 18
Study: 10828848

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for 6 months
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 81
Study: 9590915

Group type: EXPERIMENTAL
Intervention: Intraligamentary technique of anesthetic administration (ILA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Inferior alveolar nerve block (IANB)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 16
Study: 8250678

Group type: EXPERIMENTAL
Intervention: Morning light therapy (2500 lux for 1 hour for 1 week)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Evening light therapy (2500 lux for 1 hour for 1 week)
Number of subjects: 39
Study: 2951811

Group type: EXPERIMENTAL
Intervention: Combination of 40 micrograms ipratropium bromide and 100 micrograms fenoterol (Duovent)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 250 micrograms terbutaline
Number of subjects: 20
Study: 29370572

Group type: EXPERIMENTAL
Intervention: Gevokizumab (60 mg every 4 weeks subcutaneously)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 27881152

Group type: EXPERIMENTAL
Intervention: Physiotherapy with systematically augmented levels of mobilisation (5 times per week, over 2 weeks; 20 min each session; total of 10 additional sessions)
Number of subjects: 108

Group type: COMPARATOR
Intervention: In-bed cycling sessions (same number, frequency and treatment time as the intervention group)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Physiotherapy with systematically augmented levels of mobilisation
Number of subjects: 108

Group type: COMPARATOR
Intervention: In-bed cycling sessions
Number of subjects: 108
Study: 24384538

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22436075

Group type: EXPERIMENTAL
Intervention: CAF-CHO
Number of subjects: 10

Group type: COMPARATOR
Intervention: CHO
Number of subjects: 10

Group type: COMPARATOR
Intervention: CAF
Number of subjects: 10

Group type: COMPARATOR
Intervention: PLA
Number of subjects: 10
Study: 20331933

Group type: EXPERIMENTAL
Intervention: MINI‐KID
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: MINI‐KID-P
Number of subjects: 226
Study: 17987065

Group type: COMPARATOR
Intervention: Dopamine release (DA(rel)) in TS patients
Number of subjects: 14

Group type: COMPARATOR
Intervention: Dopamine D2 receptor (D2-R) density in TS patients with OCD
Number of subjects: 14

Group type: COMPARATOR
Intervention: Serotonin transporter binding potential (SERT BP) in TS patients
Number of subjects: 14

Group type: COMPARATOR
Intervention: Dopamine release (DA(rel)) and serotonin 5-HT2A receptor binding potential (5-HT2A BP) in TS+OCD subjects
Number of subjects: 14
Study: 15717937

Group type: EXPERIMENTAL
Intervention: Self-expanding metal stents (SEMS)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: 18-mm SEMS
Number of subjects: 217

Group type: COMPARATOR
Intervention: Non-stent therapies
Number of subjects: 217

Group type: COMPARATOR
Intervention: Rigid intubation
Number of subjects: 217

Group type: COMPARATOR
Intervention: Bipolar electrocoagulation and ethanol tumour necrosis
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Quality of life measures
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Survival measures
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Quality-adjusted life-years
Number of subjects: 217
Study: 12876113

Group type: EXPERIMENTAL
Intervention: Brief explanation to parents regarding the self-limited nature of AOM and the controversy regarding antibiotic prescription.
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (no brief explanation provided).
Number of subjects: 81
Study: 10378599

Group type: EXPERIMENTAL
Intervention: Augmented biofeedback
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sensory biofeedback
Number of subjects: 40
Study: 8885916

Group type: EXPERIMENTAL
Intervention: Left lateral position
Number of subjects: 15

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Right lateral position
Number of subjects: 15
Study: 2063503

Group type: EXPERIMENTAL
Intervention: Adaptogens treatment (0.15 U/kg im insulin, 0.1 mg/kg prednisolone, 0.2 mg/kg dibazol, 250 mg/kg methyluracil daily for 1 week preoperatively)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Prednisolone (0.2 mg/kg intravenous administration)
Number of subjects: 118
Study: 31445925

Group type: EXPERIMENTAL
Intervention: Straight catheters
Number of subjects: 308

Group type: COMPARATOR
Intervention: Coiled catheters
Number of subjects: 308
Study: 30225843

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: De-escalation (switching from ticagrelor to clopidogrel)
Number of subjects: 653

Group type: COMPARATOR
Intervention: De-escalation, Ticagrelor, Clopidogrel
Number of subjects: 653
Study: 26607698

Group type: EXPERIMENTAL
Intervention: Sedentary time (measured using ActiGraph GT3X accelerometer)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Sedentary time (hours/day)
Number of subjects: 263
Study: 25269669

Group type: EXPERIMENTAL
Intervention: 50,000 IU vitamin A
Number of subjects: 306

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306
Study: 22430275

Group type: EXPERIMENTAL
Intervention: Weight gain of at least 10% of prediagnosis weight
Number of subjects: 3088

Group type: EXPERIMENTAL
Intervention: Weight loss of at least 10% of prediagnosis weight
Number of subjects: 3088

Group type: COMPARATOR
Intervention: Weight stability (within 10% of prediagnosis weight)
Number of subjects: 3088

Group type: EXPERIMENTAL
Intervention: Trend of weight change (weight loss and weight gain)
Number of subjects: 3088
Study: 19996342

Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted Abrams needle biopsies
Number of subjects: 89

Group type: COMPARATOR
Intervention: Ultrasound-assisted Tru-Cut needle biopsies
Number of subjects: 89
Study: 18511529

Group type: EXPERIMENTAL
Intervention: Group exercise programme run by a physiotherapist (n = 85)
Number of subjects: 173

Group type: COMPARATOR
Intervention: No-intervention waiting list control group (n = 88)
Number of subjects: 173
Study: 15736113

Group type: EXPERIMENTAL
Intervention: Methionine (0.1 g/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Homocysteine (0.01 g/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) (0.1 g/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Methionine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Homocysteine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 10
Study: 12952516

Group type: EXPERIMENTAL
Intervention: Physiotherapy treatment without deep breathing exercises
Number of subjects: 230

Group type: COMPARATOR
Intervention: Physiotherapy treatment with deep breathing exercises (control)
Number of subjects: 230